Sumitomo Mitsui Trust Holdings, Inc. Guardant Health, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $138 Billion
- Q1 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 1,357,227 shares of GH stock, worth $65.1 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,357,227
Previous 1,464,213
7.31%
Holding current value
$65.1 Million
Previous $44.7 Million
29.25%
% of portfolio
0.04%
Previous 0.03%
Shares
20 transactions
Others Institutions Holding GH
# of Institutions
359Shares Held
116MCall Options Held
793KPut Options Held
1.85M-
Vanguard Group Inc Valley Forge, PA12.1MShares$578 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$539 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.42MShares$308 Million8.64% of portfolio
-
Baillie Gifford & CO5.45MShares$262 Million0.13% of portfolio
-
Cadian Capital Management, LP New York, NY5.22MShares$251 Million9.25% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.91B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...